IntelligentMDx Receives FDA Clearance for IMDx VanR for Abbott m2000 assay

barbara.lempert IntelligentMDx (privately held) announced today that the U.S. Food and Drug Administration (FDA) has cleared its automated molecular diagnostic test that detects the ...

Bayer’s new drugs shine, fueling 5.5% pharma growth

Tracy Staton Bayer is warning that its 2013 profits goals look a bit too ambitious now, but thanks to unexpectedly strong new-drug sales, it expects pharma revenue to jump by a high ...

FDA Decides No Risk Of Pancreatic Cancer With Diabetes Drugs

esilverman In yet another boost to several large drugmakers, the FDA has decided that there is no evidence that to confirm recent concerns that a widely used group of diabetes ...

Buzz: Hungry AstraZeneca circles a blockbuster biosimilars buyout

John Carroll Quoting sources close to the deal, Korea's Financial News says that Celltrion hooked AstraZeneca's interest after it began to cast around for a merger deal a few ...

Sanofi swaps leaders at animal health unit Merial

Tracy Staton The French drugmaker replaced Jose Barella with Carsten Hellmann, formerly of Chr. Hansen Holding; Barella is leaving to pursue other opportunities. FiercePharma News

Pfizer Agrees to $491M Justice Settlement

barbara.lempert Pfizer Agrees to $ 491M Justice Settlement; Quarterly Revenue Slips PHILADELPHIA, July 31, 2013 (PHILADELPHIA INQUIRER)–The Justice Department and Pfizer ...

NIH awards Third Rock startup up to $10M for Fragile X work

John Carroll The money is earmarked for discovery work through Phase I. And interim CEO Kevin Starr–a partner at Third Rock who launched the company with a $ 35 million A round ...

Bayer 2Q Profit Up

barbara.lempert Bayer: strong growth in Life Sciences HealthCare and CropScience post dynamic growth, MaterialScience weak / New pharmaceutical products well above expectations ...

AstraZeneca commits $815M to partner with FibroGen on anemia drug

John Carroll AstraZeneca CEO Pascal Soriot has taken another step forward in his turnaround campaign, committing $ 350 million in cash and up to $ 465 million in milestones to partner ...

Amgen, Teijin in Autoimmune Deal

barbara.lempert Teijin Pharma, Amgen to Jointly Research and Develop Novel Therapies for Autoimmune Diseases Tokyo, Japan, July 31, 2013 — Teijin Pharma Limited, the core company ...

Merck 2Q Profit Drops

barbara.lempert Merck Announces Second-Quarter 2013 Financial Results •2013 Second-Quarter Non-GAAP EPS of $ 0.84, Excluding Certain Items; GAAP EPS of $ 0.30 •Worldwide ...

FDA Lifts Clinical Hold on Cangene’s Hemophilia Compound

barbara.lempert FDA lifts clinical hold on Cangene’s hemophilia compound IB1001 TSX: CNJ Readers are referred to the cautionary note regarding Forward-looking Information ...
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS